Advancements in 3D Printing for Oral Drug Delivery

Innovations in 3D Printing Techniques for Pharmaceuticals

The advent of 3d printing technology has revolutionized the pharmaceutical industry, enabling the production of tailored medications that meet individual patient needs. Various techniques have emerged, including Fused Deposition Modeling (FDM), Stereolithography (SLA), and Selective Laser Sintering (SLS), each offering unique advantages for the development of oral drug delivery systems.

FDM has been identified as the primary technique for pharmaceutical applications. It allows for the precise layering of thermoplastic materials, which can include multiple active pharmaceutical ingredients (APIs) in one dosage form. This method is particularly beneficial for creating complex geometries that enhance drug release profiles, thus improving bioavailability (Paipa-Jabre-Cantu et al., 2025).

SLA and SLS techniques offer high precision and resolution, allowing for the production of intricate designs in oral medications. For instance, SLA utilizes light to cure liquid resins into solid forms, which can be tailored for specific drug release requirements. SLS, on the other hand, uses a laser to fuse powdered materials, creating porous structures that are advantageous for controlling drug release rates (Paipa-Jabre-Cantu et al., 2025).

Table 1: Comparison of 3D Printing Techniques for Pharmaceuticals

Key Applications of 3D Printed Oral Medications

3D printing has opened new avenues in the development of oral medications, with applications ranging from personalized pills to polypharmacy solutions. Oral dosage forms such as orodispersible films, tablets, and gel caps can be customized to meet specific patient needs, enhancing adherence and therapeutic outcomes.

One significant application is in the production of polypills, which combine multiple drugs into a single dosage form. This is particularly beneficial for patients with chronic conditions that require complex medication regimens. The ability to adjust the release profiles of individual drugs within a polypill can optimize treatment efficacy and minimize side effects (Paipa-Jabre-Cantu et al., 2025).

Furthermore, 3D printing facilitates the creation of medications that cater to specific demographics, such as pediatric or geriatric patients. For instance, formulations can be designed to be easier to swallow or to dissolve quickly in the mouth, addressing the unique challenges faced by these populations.

Materials Used in 3D Printing for Drug Formulation

The choice of materials in 3D printing for pharmaceuticals is critical, as they directly impact the performance and safety of the final product. Common materials include thermoplastic polymers like Polylactic Acid (PLA), Polyvinyl Alcohol (PVA), and Acrylonitrile Butadiene Styrene (ABS). These materials are chosen for their biocompatibility, mechanical properties, and ability to form complex structures.

PLA is widely used due to its biodegradability and compatibility with a variety of drugs. It provides a sturdy matrix for drug delivery while allowing for controlled degradation rates, which is vital for sustained drug release. PVA is favored for its water-soluble properties, making it suitable for orodispersible films and other dosage forms that require rapid disintegration upon administration (Paipa-Jabre-Cantu et al., 2025).

Table 2: Common Materials Used in 3D Printing for Pharmaceuticals

Enhancements in Patient Experience with 3D Printed Drugs

3D printing not only enhances the delivery of medications but also significantly improves the patient experience. Tailored dosages and personalized formulations lead to higher adherence rates among patients. For instance, 3D printing allows for the production of medications that are easier to swallow, have improved taste, or are designed to release drugs in a specific manner based on individual needs.

Moreover, incorporating features such as braille or distinct colors on the surface of tablets can assist visually impaired patients, ensuring that they can identify their medications easily. This level of customization is crucial, particularly for populations such as children or the elderly, who may struggle with conventional medication forms (Paipa-Jabre-Cantu et al., 2025).

Regulatory and Safety Considerations for 3D Printed Therapies

The integration of 3D printing in pharmaceuticals necessitates a thorough understanding of regulatory frameworks and safety protocols. The FDA and other regulatory bodies are currently developing guidelines for the approval and monitoring of 3D-printed drugs. These guidelines focus on ensuring the safety, efficacy, and quality of the medications produced using this technology.

Key considerations include the need for robust quality control measures to verify the consistency of drug formulations and the accuracy of dosages. Additionally, regulatory pathways must address the unique challenges posed by 3D printing, such as the reproducibility of complex designs and the stability of printed medications over time (Paipa-Jabre-Cantu et al., 2025).

Table 3: Regulatory Considerations for 3D Printed Drugs

FAQ Section

What is 3D printing in pharmaceuticals?
3D printing in pharmaceuticals refers to the use of additive manufacturing techniques to create personalized medication formulations and drug delivery systems.

How does 3D printing improve medication adherence?
By allowing for tailored dosages, easier-to-swallow forms, and enhanced patient-specific designs, 3D printing can significantly improve medication adherence, especially in populations with unique needs.

What materials are commonly used in 3D printing for oral drugs?
Common materials include PLA, PVA, and ABS, which are chosen for their biocompatibility, mechanical properties, and ability to form complex structures.

What are the regulatory considerations for 3D-printed drugs?
Regulatory considerations include ensuring quality control, developing specific approval processes for 3D-printed formulations, and monitoring the safety of these medications over time.

What are the key applications of 3D printing in medication?
Key applications include the production of polypills, orodispersible films, and personalized tablets tailored to the needs of specific patient groups.

References

1. Paipa-Jabre-Cantu, S. I., Rodriguez-Salvador, M., Castillo-Valdez, P., & Espeau, P. (2025). Revealing Three-Dimensional Printing Technology Advances for Oral Drug Delivery: Application to Central-Nervous-System-Related Diseases. Pharmaceutics, 17(4), 445. https://doi.org/10.3390/pharmaceutics17040445

2. Liu, Q., Yang, K., Xie, B., Gao, Y., Xu, S., & Lu, Y. (2025). Genomic Insights into Vector–Pathogen Adaptation in Haemaphysalis longicornis and Rhipicephalus microplus. Journal of Clinical Medicine, 14(8), 2673. https://doi.org/10.3390/jcm14082673

3. Radanovic, M., Singulani, M. P., De Paula, V. J. R., Talib, L. L., & Forlenza, O. V. (2025). An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective. Pharmaceuticals, 18(4), 532. https://doi.org/10.3390/ph18040532

4. Omidian, H., Omidian, A., & Carvalho, M. (2025). The Emergence of Psilocybin in Psychiatry and Neuroscience. Pharmaceuticals, 18(4), 555. https://doi.org/10.3390/ph18040555

5. Ogundele, M. O., & Morton, M. J. S. (2025). Subthreshold Autism and ADHD: A Brief Narrative Review for Frontline Clinicians. Pediatric Reports, 17(2), 42. https://doi.org/10.3390/pediatric17020042